Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Bibliográfalaš dieđut
Váldodahkkit: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Materiálatiipa: Conference item
Almmustuhtton: 2009